Search research articles
Contact Us
Filters
Showing results (1-10 of 144) with videos related to
Page
of 15
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
February 19, 2008
Advances in triple receptor-negative breast cancer
Ana M Gonzalez-Angulo
The Oncologist
|
January 24, 2012
To biopsy or not to biopsy: is that the only question?
Shaheenah Dawood, Ana M Gonzalez-Angulo
Cancer Prevention Research (Philadelphia, Pa.)
|
April 3, 2012
Metformin and hepatic carcinogenesis
Michael Pollak, Ana M Gonzalez-Angulo
Cancer Biomarkers : Section a of Disease Markers
|
June 6, 2013
Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer
Shaheenah Dawood, Ana M Gonzalez-Angulo
Oncology (Williston Park, N.Y.)
|
September 11, 2012
Hormone receptor-positive breast cancer: the known and the unknown
Shaheenah Dawood, Ana M Gonzalez-Angulo
The Oncologist
|
June 7, 2013
Progress in the biological understanding and management of breast cancer-associated central nervous system metastases
Shaheenah Dawood, Ana M Gonzalez-Angulo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Metformin: a therapeutic opportunity in breast cancer
Ana M Gonzalez-Angulo, Funda Meric-Bernstam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Optimal schedule of paclitaxel: weekly is better
Ana M Gonzalez-Angulo, Gabriel N Hortobagyi
Onkologie
|
April 15, 2010
Brain metastases and breast cancer subtypes
Ana M Gonzalez-Angulo, Gabriel N Hortobagyi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Is there an ideal way to combine trastuzumab with chemotherapy?
Ana M Gonzalez-Angulo, Gabriel N Hortobagyi
Page
of 15
Search research articles
Search
Showing results (1-10 of 144) with videos related to
Sort By:
Page
of 15
Clinical Advances in Hematology & Oncology : H&O
|
February 19, 2008
Advances in triple receptor-negative breast cancer
Ana M Gonzalez-Angulo
The Oncologist
|
January 24, 2012
To biopsy or not to biopsy: is that the only question?
Shaheenah Dawood, Ana M Gonzalez-Angulo
Cancer Prevention Research (Philadelphia, Pa.)
|
April 3, 2012
Metformin and hepatic carcinogenesis
Michael Pollak, Ana M Gonzalez-Angulo
Cancer Biomarkers : Section a of Disease Markers
|
June 6, 2013
Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer
Shaheenah Dawood, Ana M Gonzalez-Angulo
Oncology (Williston Park, N.Y.)
|
September 11, 2012
Hormone receptor-positive breast cancer: the known and the unknown
Shaheenah Dawood, Ana M Gonzalez-Angulo
The Oncologist
|
June 7, 2013
Progress in the biological understanding and management of breast cancer-associated central nervous system metastases
Shaheenah Dawood, Ana M Gonzalez-Angulo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Metformin: a therapeutic opportunity in breast cancer
Ana M Gonzalez-Angulo, Funda Meric-Bernstam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Optimal schedule of paclitaxel: weekly is better
Ana M Gonzalez-Angulo, Gabriel N Hortobagyi
Onkologie
|
April 15, 2010
Brain metastases and breast cancer subtypes
Ana M Gonzalez-Angulo, Gabriel N Hortobagyi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Is there an ideal way to combine trastuzumab with chemotherapy?
Ana M Gonzalez-Angulo, Gabriel N Hortobagyi
Page
of 15